Iron Pill-Induced Gastritis in a Pediatric Patient Taking Ferrous Sulfate Tablets

Charles B Chen1, Shreeya Chugh2, Deepthi Rao3

  • 1Division of Gastroenterology (CBC), Department of Pediatrics, University of Missouri School of Medicine, Columbia, MO.

Insights

Iron supplementation can cause gastritis in children. Switching from oral ferrous sulfate tablets to liquid form resolved iron pill-induced gastritis in an 11-year-old boy, as confirmed by repeat endoscopy.

Area of Science:

  • Pediatric Gastroenterology
  • Hematology
  • Gastrointestinal Pathology

Background:

  • Iron deficiency anemia is common in children.
  • Oral iron supplementation, particularly ferrous sulfate, is a standard treatment.
  • Adverse gastrointestinal effects can occur with oral iron therapy.

Purpose of the Study:

  • To report a case of iron pill-induced gastritis in a pediatric patient.
  • To highlight the diagnostic findings and management of this condition.
  • To emphasize the importance of considering medication side effects in pediatric gastrointestinal symptoms.

Main Methods:

  • A case report of an 11-year-old male treated with oral ferrous sulfate tablets.
  • Diagnostic endoscopy with histological examination to identify iron deposition.
  • Clinical follow-up and repeat endoscopy after changing iron formulation.

Main Results:

  • The patient developed iron pill-induced gastritis, evidenced by histological iron deposition.
  • Switching iron supplementation from tablets to liquid form led to symptom resolution.
  • Repeat endoscopy confirmed the resolution of gastritis after 4 months.

Conclusions:

  • Oral ferrous sulfate tablets can cause gastritis in children.
  • Iron pill-induced gastritis is reversible with appropriate management.
  • Formulation change to liquid iron may prevent or resolve this adverse effect.

Related Concept Videos

Other Disorders of Digestive System01:30

Other Disorders of Digestive System

The gastrointestinal tract is susceptible to various disorders. If the lower esophageal sphincter is damaged, stomach acid can flow back into the esophagus, causing irritation and inflammation of the lining. This condition is called gastroesophageal reflux disease (known as heartburn) and may cause chest pain and difficulty swallowing. In the stomach, prolonged use of nonsteroidal anti-inflammatory drugs like aspirin, chronic alcohol consumption, bacterial infections such as Helicobacter...
742
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
161
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
192
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
78
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents01:24

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents

In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
417
Gastritis-I: Introduction and Types01:27

Gastritis-I: Introduction and Types

Gastritis, defined by the inflammation or irritation of the stomach lining or gastric mucosa, manifests in several distinct forms: acute, chronic, reactive, and a specific subtype known as autoimmune metaplastic atrophic gastritis.
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
317